Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V6GX
|
|||
| Former ID |
DNC007528
|
|||
| Drug Name |
BX-201
|
|||
| Synonyms |
BX-201; indolinone based inhibitor, 3l; CHEMBL442229; SCHEMBL5728132; BDBM16981
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H12N4O2
|
|||
| Canonical SMILES |
C1=CNC(=C1)C=C2C3=C(C=CC(=C3)NC(=O)N)NC2=O
|
|||
| InChI |
1S/C14H12N4O2/c15-14(20)17-9-3-4-12-10(7-9)11(13(19)18-12)6-8-2-1-5-16-8/h1-7,16H,(H,18,19)(H3,15,17,20)/b11-6-
|
|||
| InChIKey |
SOVOJYOIAXOTIM-WDZFZDKYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3814-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.